biomedical product News
-
CENTOGENE and Molecular Health Announce an Exclusive Collaboration With the Aim to Transform the Development of Orphan Drugs
The combination of real-life data sets in rare diseases with innovative big data/artificial intelligence/novel scientific computational knowledge will transform biomedical research, product development, and therapy. Real-life data and Innovative Bioinformatic Algorithms (RIBA project) will enable the creation of a powerful environment to accelerate, de-risk, and improve the development of new ...
-
Lumen Bioscience Awarded $3.6 Million by U.S. Army to Advance Low-cost, Scalable Preventative for Antibiotic-Resistant Infections
Lumen Bioscience—a clinical-stage biopharmaceutical company developing biologic drugs for highly prevalent diseases—today announced the receipt of a $3.6 million award from the Department of Defense (DoD) for advanced biomedical product development in support of Naval operations. The award from the Medical Technology Consortium (MTEC), a 501(c)(3) biomedical technology consortium ...
-
ABK Biomedical Announces First Patient Treated in First-in-Human Clinical Study with Eye90 microspheres™ for treatment of liver tumors
ABK Biomedical, Inc., an innovative, clinical-stage medical device company dedicated to the research, development and commercialization of advanced imageable embolic therapies, announced the first patient treated in ABK’s First-in-Human study with Eye90 microspheres™, a Y90 radioembolization device for the treatment of liver cancers. This study is being conducted in collaboration ...
-
CytoRecovery Presents Data at the 2022 American Association for Cancer Research (AACR) Annual Meeting
CytoRecovery, Inc., a leader in the marker free enrichment, sorting, and recovery of live cells, presented recent study results at the American Association for Cancer Research (AACR) Annual Meeting 2022 currently being held in New Orleans. The study was completed in collaboration with The Laboratory of Integrative Cancer Immunology, National Cancer Institute (NCI/NIH Bethesda, MD) and Virginia ...
-
N8 Medical Announces NHLBI Grant to Develop Antimicrobial Pacemaker Envelope
N8 Medical, LLC (N8 Medical) today announced that the National Heart Lung and Blood Institute (NHLBI) of the National Institutes of Health (NIH) indicated its intent to fund N8 Medical’s STTR Phase I grant application for the development of a resorbable envelope to prevent surgical site infections associated with pacemaker implantation surgeries. N8 Medical will be working with researchers ...
-
New mission statement, new business units, new logo
We are proud to announce we have re-organized into two separate business units, Biorep Technologies, and Biorep Diabetes.With this change, we’re also announcing separate mission statements and a new unifying logo. This change was prompted due to our ongoing transition from a company solely focused on islet isolation and transplantation technologies, to a provider of medical device product ...
-
HORIBA announces the acquisition of the global assets of Photon Technology International, expanding its reach in the biomedical field.
HORIBA announces the acquisition of the global assets of Photon Technology International, Inc. and its affiliate companies (Photon Technology International or PTI). HORIBA Instruments Inc. (based in the U.S.) and other HORIBA Scientific group companies have acquired PTI’s worldwide business assets with the aim of increasing market share in fluorescence spectroscopy by taking advantage of ...
-
World Health Report calls for return to primary health care approach
The World Health Report 2008, launched recently, critically assesses the way that health care is organized, financed, and delivered in rich and poor countries around the world. The WHO report documents a number of failures and shortcomings that have left the health status of different populations, both within and between countries, dangerously out of balance. “The World Health Report sets out a ...
-
UPM Biomedicals fights cancer with GrowDex®
Cancer is the second leading cause of death globally, and unfortunately a growing global burden. With an estimated 18 million cancer cases yearly around the world, cancer is one of the most significant public health challenges of the 21st century. UPM Biomedicals joins the fight against cancer with a wood-based hydrogel, GrowDex®. The hydrogel made of birch and water supports cell growth by ...
By UPM
-
DSM reports very strong Q1 2011 continuing its positive momentum
Q1 EBITDA from continuing operations up 14% to € 325 million Life Sciences results driven by ongoing good performance in Nutrition Materials Sciences posts solid results reflecting volume gains and pricing strength EPS € 0.91, 30% higher also due to a lower tax rateMartek integration underway; EBITDA in line with expectations2011 is expected to be a strong year for ...
-
Centurion Medical Products Acquires Mirador Biomedical
Centurion Medical Products has recently acquired Mirador Biomedical of Seattle, Washington. With the addition of Mirador Biomedical, Centurion continues its commitment to providing innovative products that promote more efficient procedures, better patient care, and improved financial results. Mirador is the inventor and manufacturer of the Compass family of medical devices. Compass devices ...
-
Synergy Biomedical Announces FDA Clearance of BIOSPHERE FLEX
Synergy Biomedical, LLC, a developer of innovative biomaterial products, announced today that it has received FDA 510(k) clearance of BIOSPHERE® FLEX and is targeting a launch in the 4th quarter of 2018. Based on Synergy’s BioSphere® Technology, BIOSPHERE® FLEX is composed of porous, bioactive glass granules combined with a porous collagen and sodium hyaluronate scaffold. The ...
-
Amerigo Scientific Launches Anex® Brush for Optimal Sampling
Amerigo Scientific, a distributor focused on providing critical products and services to the biomedical and life science communities, recently announced the release of a new Anex® Brush that allowed optimal sampling the entire anal canal including the anal transformation zone, without the need for a proctoscope or anoscope. Amerigo Scientific provides high-quality and cost-effective medical ...
-
Amerigo Scientific Introduces the Launch of Polystreptavidin 350
Amerigo Scientific, a distribution company focused on providing critical products and services to the biomedical and life science research communities, now introduces Polystreptavidin 350 for applications in lateral flow, ELISA or CLIA. Diagnosis is a key enabler of universal health coverage and the first line of defense against the spread of many diseases. From rapid treatment and combating ...
-
Amerigo Scientific Launches 2',3'-Diacetyl Guanosine (n-ibu)
Amerigo Scientific, a distribution company focused on providing critical products and services to the biomedical and life science research communities, now introduces 2′,3′-Diacetyl Guanosine (n-ibu) for life science applications. This 2′,3′-Diacetyl Guanosine (n-ibu) is an addition of Amerigo Scientific’s portfolio of Mononucleotides and Nucleosides. Nucleosides are ...
-
Amerigo Scientific Launches New Polyclonal Antibody to Human Blood Coagulation Factor XIII
Amerigo Scientific, a distributor focused on providing critical products and services to the biomedical and life science communities, recently announced the launch of its new polyclonal antibody to human blood coagulation factor XIII to support researchers in life science fields for the detection of blood coagulation factor XIII. This antibody is used for research only, not for human, therapeutic ...
-
ABK Biomedical partners with the CNIC to enhance patient care
ABK Biomedical, which is developing a transformative Eye90 microspheres® technology, with the potential to provide in-procedure prognostic dosimetry for cutting-edge treatment of liver tumours – has partnered with the Canadian Nuclear Isotope Council. The CNIC is an independent body made up of representatives from the Canadian health sector, nuclear industry and leading research ...
-
Bexson Biomedical Granted USPTO Patent Allowance on Proprietary Formulation Technology, SeValent
Bexson Biomedical, Inc., a biopharmaceutical company focused on disrupting the small molecule injectable market and enabling home health solutions, today announced the U.S. Patent and Trademark Office (USPTO) has issued a Notice of Allowance for U.S. Application No. 17/546,880 filed on December 9, 2021 and titled Complexing Agent Salt Formulations of Pharmaceutical Compounds. Bexson’s ...
-
KLISBio to feature engineered silk innovation at Biotech Showcase
Investors keen to get involved with a company on the forefront of human tissue regeneration will be interested to visit with KLISBio, an international medtech company bringing its silk-based biomedical technology and the first of their products, SILKBridge®, to the Biotech Showcase Jan. 10-19. KLISBio is leading a revolution in restorative surgical procedures using engineered silk ...
By KLISBio
-
Signature Orthopaedics and Halifax Biomedical Inc join forces to improve product safety through enhanced joint replacement monitoring
Signature Orthopaedics, an Australian-based designer and developer of innovative medical devices and instrumentation, has teamed up with Canadian-based Halifax Biomedical Inc to offer HALIFAX monitoring to patients who receive Signature joint replacement implants. HALIFAX monitoring includes the implantation of small markers into the patient’s bone during surgery and uses HALIFAX stereo ...
Need help finding the right suppliers? Try XPRT Sourcing. Let the XPRTs do the work for you